News Article
Amolyt Pharma is presenting data at ECE 2022 and ENDO 2022
19 May 2022

Amolyt Pharma has announced its accepted abstracts that will be presented at the European Congress of Endocrinology (ECE 2022) and the Endocrine Society Meeting (ENDO 2022). The selection covers new data on treatments for rare endocrine diseases, including acromegaly and parathyroid disorders.